CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company
CS MEDICA A/S announces today that CEO, Lone Henriksen has acquired in total of 7.610 shares in CS MEDICA at an average price of DKK 4,16, amounting to a total value of DKK 31.628,35.
CEO of CS MEDICA, Lone Henriksen, has purchased 7.610 shares in the open market at an average price of DKK 4,16 per share, corresponding to a total purchase of DKK 31.628,35. Following the transaction, Lone Henriksen owns 4.174.180 CS MEDICA shares.
This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 25-04-2024 11:04 CET.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/
CS MEDICA, a Danish MedTech pioneer, specializes in developing evidence-based, CBD-integrated treatments for pain management, autoimmune and stress-related disorders. With a focus on patient-centric care, our products range from innovative R&D to registered over-the-counter substance-based medical devices and dermaceuticals. Our flagship CANNASEN® brand, alongside our own-label solutions, exemplifies our dedication to safe, high-quality treatments for both human and veterinary health globally.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com and LinkedIn.
Tags: